Your browser doesn't support javascript.
loading
Discrepant antitumor efficacies of three CpG oligodeoxynucleotide classes in monotherapy and co-therapy with PD-1 blockade.
Li, Tete; Hua, Cong; Yue, Wenjun; Wu, Jing; Lv, Xinping; Wei, Qiuyu; Zhu, Shan; Zang, Guoxia; Cui, Jiuwei; Liu, Yong-Jun; Chen, Jingtao.
Afiliación
  • Li T; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, 130061, China. Electronic address: litete17@163.com.
  • Hua C; Department of Neurosurgery, The First Hospital of Jilin University, Changchun 130021, China. Electronic address: huacong@jlu.edu.cn.
  • Yue W; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, 130061, China. Electronic address: yuewj17@mails.jlu.edu.cn.
  • Wu J; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, 130061, China. Electronic address: wujing2012@jlu.edu.cn.
  • Lv X; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, 130061, China. Electronic address: lvxp17@mails.jlu.edu.cn.
  • Wei Q; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, 130061, China. Electronic address: weiqy19@mails.jlu.edu.cn.
  • Zhu S; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, 130061, China. Electronic address: zhus239@jlu.edu.cn.
  • Zang G; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, 130061, China. Electronic address: guoxiaz520@126.com.
  • Cui J; Cancer Center, The First Hospital of Jilin University, Changchun 130021, China. Electronic address: cuijw@jlu.edu.cn.
  • Liu YJ; Sanofi Research and Development, Cambridge, MA 02139, USA. Electronic address: yong-jun.liu@sanofi.com.
  • Chen J; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, 130061, China; Cancer Center, The First Hospital of Jilin University, Changchun 130021, China. Electronic address: jtchen@jlu.edu.cn.
Pharmacol Res ; 161: 105293, 2020 11.
Article en En | MEDLINE | ID: mdl-33176206
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oligodesoxirribonucleótidos / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Colon / Islas de CpG / Receptor Toll-Like 9 / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico Límite: Animals Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oligodesoxirribonucleótidos / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Colon / Islas de CpG / Receptor Toll-Like 9 / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico Límite: Animals Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2020 Tipo del documento: Article